GS-441524 and remdesivir: where we started and what we have learnt
Overview
Learning Objectives:
- Summarise the evidence supporting GS-441524 and remdesivir as effective treatments for FIP.
- Explain current consensus recommendations (ISCAID treatment guideline) regarding first-line antiviral therapy for FIP.
- Compare GS-441524 and remdesivir with other nucleoside analogues in terms of evidence and clinical outcomes.
- Describe key lessons learned about dose optimisation and preferred route of administration across different clinical presentations of FIP.
Presenters
FIP – Facts, Insights & Progress Module 1: Foundations & Pathogenesis | Module 2:…
An FIP diagnosis can turn a caregiver’s world upside down, and the flood of misinformation online…
Pathogenesis of FIP: current research areas and hypotheses Register here Learning Objectives …
Load More
